Trial Profile
Efficacy of extended release quetiapine in patients with anxious unipolar major depressive disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 03 Apr 2017 New trial record